Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. [electronic resource]
Producer: 20050330Description: 488-98 p. digitalISSN:- 0007-0920
- Adenocarcinoma -- radiotherapy
- Aged
- Androgen Antagonists -- therapeutic use
- Cyproterone -- therapeutic use
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoadjuvant Therapy
- Pilot Projects
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- radiotherapy
- Radiation Injuries
- Radiotherapy Dosage
- Radiotherapy, Conformal -- adverse effects
- Rectum -- radiation effects
- Treatment Outcome
- Urinary Bladder -- radiation effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.